Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation
Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lip...
Saved in:
Published in | Journal of molecular medicine (Berlin, Germany) Vol. 98; no. 7; pp. 973 - 983 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.07.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis.
Key messages
OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages.
Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling.
Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group.
Vimentin concentration is strongly correlated with oxLDL concentration in serum. |
---|---|
AbstractList | Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis.
Key messages
OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages.
Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling.
Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group.
Vimentin concentration is strongly correlated with oxLDL concentration in serum. Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum. Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis.Key messagesOxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages.Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling.Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group.Vimentin concentration is strongly correlated with oxLDL concentration in serum. Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum. |
Author | Cho, Wonkyoung Lee, Sang-Hak Oh, Goo Taeg Park, Young Mi Kim, SeoYeon Kim, Inyeong |
Author_xml | – sequence: 1 givenname: SeoYeon surname: Kim fullname: Kim, SeoYeon organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University – sequence: 2 givenname: Wonkyoung surname: Cho fullname: Cho, Wonkyoung organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University – sequence: 3 givenname: Inyeong surname: Kim fullname: Kim, Inyeong organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University – sequence: 4 givenname: Sang-Hak surname: Lee fullname: Lee, Sang-Hak organization: Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine – sequence: 5 givenname: Goo Taeg surname: Oh fullname: Oh, Goo Taeg organization: Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University – sequence: 6 givenname: Young Mi orcidid: 0000-0001-6558-7410 surname: Park fullname: Park, Young Mi email: parkym@ewha.ac.kr organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32451671$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1P3DAQhq0KVBbaP9BDFamXXlLGH7HXRwT9klbiAmfLcSZglNiL7RTor69haStx4GLL0vOMZ-Y9JHshBiTkA4UvFEAdZwAKugUGLVDNeHv3hqyo4KylQsAeWYEWsmWKygNymPNNxVWnxVtywJnoqFR0Rcbzez_43zg0m7NN48OwOMzNLz9jKD40GV3C4mNo-odmti7F7bW9qoQNQ-NiKMn3S6nvEhtbrjHF7KZ6Fu9qsXGy82wf9Xdkf7RTxvfP9xG5_Pb14vRHuzn__vP0ZNM6QXVpFeudw7VSgnGNoAZggik51jGpok4JpJ121PJRyY4qKfueDU52wAZAve75Efm8q7tN8XbBXMzss8NpsgHjkg0TIHXH-JpX9NML9CYuKdTuKsUoE4KBrNTHZ2rpZxzMNvnZpgfzd4MVYDug7ibnhOM_hIJ5jMnsYjI1JvMUk7mr0vqF5Hx5WlRJ1k-vq3yn5vpPuML0v-1XrD9jJabS |
CitedBy_id | crossref_primary_10_1007_s13402_023_00844_3 crossref_primary_10_1016_j_isci_2023_107145 crossref_primary_10_1186_s12964_025_02062_w crossref_primary_10_4093_dmj_2022_0332 crossref_primary_10_1016_j_phymed_2022_154305 crossref_primary_10_1007_s00109_021_02109_8 crossref_primary_10_1016_j_chemphyslip_2023_105362 crossref_primary_10_3390_biomedicines10040828 crossref_primary_10_12677_ACM_2023_1392064 crossref_primary_10_1016_j_ijcard_2021_07_010 crossref_primary_10_1186_s12967_022_03562_w crossref_primary_10_3389_fcvm_2022_879726 crossref_primary_10_1111_imcb_12721 crossref_primary_10_1161_STROKEAHA_120_032111 crossref_primary_10_31857_S0320972524040113 crossref_primary_10_1096_fj_202402322R crossref_primary_10_1089_dna_2021_0623 crossref_primary_10_1161_JAHA_122_027862 crossref_primary_10_3389_fimmu_2022_837180 crossref_primary_10_1016_j_ceb_2025_102483 crossref_primary_10_1016_j_ceb_2023_102265 crossref_primary_10_1016_j_ceb_2023_102246 crossref_primary_10_3389_fcell_2022_891281 crossref_primary_10_1007_s11883_020_00870_8 crossref_primary_10_3390_v14081814 crossref_primary_10_1134_S0006297924040114 crossref_primary_10_3390_ijms21134675 crossref_primary_10_3390_v13122471 crossref_primary_10_1038_s41419_024_07166_8 crossref_primary_10_1016_j_bbcan_2023_188985 crossref_primary_10_1002_bies_202000078 crossref_primary_10_3390_ijms22147469 crossref_primary_10_1016_j_jbc_2023_104963 |
Cites_doi | 10.1007/s11886-008-0078-1 10.1016/j.cardiores.2005.09.009 10.1038/nature04768 10.1161/01.ATV.20.8.1953 10.1038/ncb898 10.1096/fj.09-151639 10.1093/eurheartj/ehv759 10.2174/1568010054022024 10.1161/01.ATV.16.12.1573 10.1016/j.virol.2013.06.009 10.1134/S0006297908130063 10.1016/B978-1-4831-9942-9.50008-5 10.1016/j.atherosclerosis.2015.02.005 10.1161/01.ATV.20.10.2243 10.1038/s41598-018-34659-2 10.1016/j.cytogfr.2015.04.003 10.1161/CIRCULATIONAHA.104.529297 10.1242/jcs.182097 10.1186/1471-2172-14-6 10.1038/srep35234 10.1016/j.ijcard.2019.02.032 10.1091/mbc.e04-03-0272 10.1093/cvr/cvt117 10.1161/01.ATV.21.5.844 10.1038/nature01323 10.1016/S0021-9258(19)50272-1 10.1242/jcs.111.13.1897 10.2147/ijicmr.S64894 10.12688/f1000research.15967.1 |
ContentType | Journal Article |
Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2020 Springer-Verlag GmbH Germany, part of Springer Nature 2020. |
Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020 – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020. |
DBID | AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s00109-020-01923-w |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection (NC LIVE) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1440 |
EndPage | 983 |
ExternalDocumentID | 32451671 10_1007_s00109_020_01923_w |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: NRF-2015M3A9B6029133 |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFEXP AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7R Z7U Z7W Z7Z Z82 Z83 Z87 Z8M Z8O Z8Q Z8T Z8V Z8W Z91 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ADHKG AFDZB AFOHR AGQPQ AHPBZ ATHPR AYFIA CITATION PHGZM PHGZT NPM 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c419t-72bcce8774239e07d024276f109171c74e159c1a3f7651766bb2dc6502d0e98b3 |
IEDL.DBID | 7X7 |
ISSN | 0946-2716 1432-1440 |
IngestDate | Thu Jul 10 17:43:03 EDT 2025 Sat Aug 23 14:30:29 EDT 2025 Wed Feb 19 02:29:49 EST 2025 Tue Jul 01 02:55:38 EDT 2025 Thu Apr 24 23:08:39 EDT 2025 Fri Feb 21 02:25:55 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Vimentin NF-κB signaling TNF-α Intermediate filament Oxidized LDL Atherosclerosis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c419t-72bcce8774239e07d024276f109171c74e159c1a3f7651766bb2dc6502d0e98b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6558-7410 |
OpenAccessLink | https://ir.ymlib.yonsei.ac.kr/handle/22282913/183875 |
PMID | 32451671 |
PQID | 2421244206 |
PQPubID | 48876 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2406952383 proquest_journals_2421244206 pubmed_primary_32451671 crossref_primary_10_1007_s00109_020_01923_w crossref_citationtrail_10_1007_s00109_020_01923_w springer_journals_10_1007_s00109_020_01923_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-07-01 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: New York |
PublicationTitle | Journal of molecular medicine (Berlin, Germany) |
PublicationTitleAbbrev | J Mol Med |
PublicationTitleAlternate | J Mol Med (Berl) |
PublicationYear | 2020 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Yurdagul, Sulzmaier, Chen, Pattillo, Schlaepfer, Orr (CR19) 2016; 129 Toshima, Hasegawa, Kurabayashi, Itabe, Takano, Sugano, Shimamura, Kimura, Michishita, Suzuki, Nagai (CR21) 2000; 20 Park, Febbraio, Silverstein (CR13) 2009; 119 Li, Mehta (CR16) 2005; 68 Janabi, Yamashita, Hirano, Sakai, Hiraoka, Matsumoto, Zhang, Nozaki, Matsuzawa (CR18) 2000; 20 Szilagyi, Gijbels, van der Velden, Heinsbroek, Kraal, de Winther, van den Berg (CR8) 2015; 239 Bisgaard, Mogensen, Rosendahl, Cucak, Nielsen, Rasmussen, Pedersen (CR26) 2016; 6 Fay, Panté (CR4) 2013; 444 Gilchrist, Thorsson, Li, Rust, Korb, Kennedy, Hai, Bolouri, Aderem (CR15) 2006; 441 Thiagarajan, Yakubenko, Elsori, Yadav, Willard, Tan, Rodriguez, Febbraio, Cathcart (CR7) 2013; 99 Nagatoshi, Kazuo (CR10) 2005; 4 Meisinger, Baumert, Khuseyinova, Loewel, Koenig (CR30) 2005; 112 Endemann, Stanton, Madden, Bryant, White, Protter (CR24) 1993; 268 Wang, Yu, Cao, Wang, Zheng, Tan, Zhao, Zhao, Wang, Harris (CR25) 2013; 14 Mor-Vaknin, Punturieri, Sitwala, Markovitz (CR6) 2003; 5 Eckes, Dogic, Colucci-Guyon, Wang, Maniotis, Ingber, Merckling, Langa, Aumailley, Delouvee (CR3) 1998; 111 CR29 Hatch (CR14) 1968; 6 Holvoet, Mertens, Verhamme, Bogaerts, Beyens, Verhaeghe, Collen, Muls, Werf (CR20) 2001; 21 Tousoulis, Oikonomou, Economou, Crea, Kaski (CR27) 2016; 37 Minin, Moldaver (CR1) 2009; 73 Mendez, Kojima, Goldman (CR5) 2010; 24 Jovinge, Ares, Kallin, Nilsson (CR17) 1996; 16 Ramji, Davies (CR28) 2015; 26 CR22 Gong, Dai, Chen, Wang, Yan, Shen, Liu, Yang, Hu, Yu, Liu, Zhang, Shen, Chen, Ding, Lu (CR9) 2019; 283 Libby (CR11) 2002; 420 Styers, Salazar, Love, Peden, Kowalczyk, Faundez (CR2) 2004; 15 Todd, Brown (CR12) 2008; 10 Haversen, Sundelin, Mardinoglu, Rutberg, Stahlman, Wilhelmsson, Hulten, Pekny, Fogelstrand, Bentzon (CR23) 2018; 8 D Li (1923_CR16) 2005; 68 MG Mendez (1923_CR5) 2010; 24 M Todd (1923_CR12) 2008; 10 C Wang (1923_CR25) 2013; 14 PS Thiagarajan (1923_CR7) 2013; 99 P Libby (1923_CR11) 2002; 420 M Janabi (1923_CR18) 2000; 20 L Haversen (1923_CR23) 2018; 8 LS Bisgaard (1923_CR26) 2016; 6 1923_CR22 YM Park (1923_CR13) 2009; 119 B Eckes (1923_CR3) 1998; 111 DP Ramji (1923_CR28) 2015; 26 K Szilagyi (1923_CR8) 2015; 239 1923_CR29 S Jovinge (1923_CR17) 1996; 16 G Endemann (1923_CR24) 1993; 268 P Holvoet (1923_CR20) 2001; 21 DH Gong (1923_CR9) 2019; 283 N Fay (1923_CR4) 2013; 444 A Yurdagul Jr (1923_CR19) 2016; 129 N Mor-Vaknin (1923_CR6) 2003; 5 FT Hatch (1923_CR14) 1968; 6 S Toshima (1923_CR21) 2000; 20 ML Styers (1923_CR2) 2004; 15 C Meisinger (1923_CR30) 2005; 112 AA Minin (1923_CR1) 2009; 73 M Gilchrist (1923_CR15) 2006; 441 F Nagatoshi (1923_CR10) 2005; 4 D Tousoulis (1923_CR27) 2016; 37 |
References_xml | – volume: 10 start-page: 497 issue: 6 year: 2008 end-page: 504 ident: CR12 article-title: Biomarkers of atherosclerosis: clinical applications publication-title: Curr Cardiol Rep doi: 10.1007/s11886-008-0078-1 – volume: 68 start-page: 353 year: 2005 end-page: 354 ident: CR16 article-title: Oxidized LDL, a critical factor in atherogenesis publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2005.09.009 – volume: 441 start-page: 173 year: 2006 end-page: 178 ident: CR15 article-title: Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4 publication-title: Nature doi: 10.1038/nature04768 – volume: 20 start-page: 1953 issue: 8 year: 2000 end-page: 1960 ident: CR18 article-title: Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.8.1953 – ident: CR22 – volume: 268 start-page: 11811 issue: 16 year: 1993 end-page: 11816 ident: CR24 article-title: CD36 is a receptor for oxidized low density lipoprotein publication-title: J Biol Chem – volume: 5 start-page: 59 year: 2003 end-page: 63 ident: CR6 article-title: Vimentin is secreted by activated macrophages publication-title: Nat Cell Biol doi: 10.1038/ncb898 – volume: 24 start-page: 1838 year: 2010 end-page: 1851 ident: CR5 article-title: Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition publication-title: FASEB J doi: 10.1096/fj.09-151639 – volume: 37 start-page: 1723 year: 2016 end-page: 1732 ident: CR27 article-title: Inflammatory cytokines in atherosclerosis: current therapeutic approaches publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv759 – volume: 4 start-page: 281 year: 2005 end-page: 286 ident: CR10 article-title: Macrophages in inflammation publication-title: Curr Drug Targets Inflamm Allergy doi: 10.2174/1568010054022024 – volume: 111 start-page: 1897 year: 1998 end-page: 1907 ident: CR3 article-title: Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts publication-title: J Cell Sci – ident: CR29 – volume: 16 start-page: 1573 year: 1996 end-page: 1579 ident: CR17 article-title: Human monocytes/macrophages release TNF-{alpha} in response to ox-LDL publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.16.12.1573 – volume: 444 start-page: 181 year: 2013 end-page: 190 ident: CR4 article-title: The intermediate filament network protein, vimentin, is required for parvoviral infection publication-title: Virology doi: 10.1016/j.virol.2013.06.009 – volume: 73 start-page: 1453 year: 2009 end-page: 1466 ident: CR1 article-title: Intermediate vimentin filaments and their role in intracellular organelle distribution publication-title: Biochem Mosc doi: 10.1134/S0006297908130063 – volume: 6 start-page: 1 year: 1968 end-page: 68 ident: CR14 article-title: Practical methods for plasma lipoprotein analysis publication-title: Adv Lipid Res doi: 10.1016/B978-1-4831-9942-9.50008-5 – volume: 239 start-page: 318 year: 2015 end-page: 321 ident: CR8 article-title: Dectin-1 deficiency does not affect atherosclerosis development in mice publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.02.005 – volume: 119 start-page: 136 year: 2009 end-page: 145 ident: CR13 article-title: CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima publication-title: J Clin Invest – volume: 20 start-page: 2243 issue: 10 year: 2000 end-page: 2247 ident: CR21 article-title: Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.10.2243 – volume: 8 start-page: 16973 year: 2018 ident: CR23 article-title: Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice publication-title: Sci Rep doi: 10.1038/s41598-018-34659-2 – volume: 26 start-page: 673 year: 2015 end-page: 685 ident: CR28 article-title: Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2015.04.003 – volume: 112 start-page: 651 year: 2005 end-page: 657 ident: CR30 article-title: Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged Men from the general population publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.529297 – volume: 129 start-page: 1580 year: 2016 end-page: 1591 ident: CR19 article-title: Oxidized LDL induces FAK-dependent RSK signaling to drive NF-kappaB activation and VCAM-1 expression publication-title: J Cell Sci doi: 10.1242/jcs.182097 – volume: 14 start-page: 6 year: 2013 ident: CR25 article-title: Characterization of murine macrophages from bone marrow, spleen and peritoneum publication-title: BMC Immunol doi: 10.1186/1471-2172-14-6 – volume: 6 start-page: 35234 year: 2016 ident: CR26 article-title: Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1/M2 marker expression - implications for atherosclerosis research publication-title: Sci Rep doi: 10.1038/srep35234 – volume: 283 start-page: 9 year: 2019 end-page: 16 ident: CR9 article-title: Secretory vimentin is associated with coronary artery disease in patients and induces atherogenesis in ApoE(-/-) mice publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2019.02.032 – volume: 15 start-page: 5369 year: 2004 end-page: 5382 ident: CR2 article-title: The endo-lysosomal sorting machinery interacts with the intermediate filament cytoskeleton publication-title: Mol Biol Cell doi: 10.1091/mbc.e04-03-0272 – volume: 99 start-page: 494 year: 2013 end-page: 504 ident: CR7 article-title: Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvt117 – volume: 21 start-page: 844 year: 2001 end-page: 848 ident: CR20 article-title: Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.21.5.844 – volume: 420 start-page: 868 year: 2002 end-page: 874 ident: CR11 article-title: Inflammation in atherosclerosis publication-title: Nature doi: 10.1038/nature01323 – volume: 6 start-page: 1 year: 1968 ident: 1923_CR14 publication-title: Adv Lipid Res doi: 10.1016/B978-1-4831-9942-9.50008-5 – volume: 268 start-page: 11811 issue: 16 year: 1993 ident: 1923_CR24 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)50272-1 – volume: 6 start-page: 35234 year: 2016 ident: 1923_CR26 publication-title: Sci Rep doi: 10.1038/srep35234 – volume: 15 start-page: 5369 year: 2004 ident: 1923_CR2 publication-title: Mol Biol Cell doi: 10.1091/mbc.e04-03-0272 – volume: 111 start-page: 1897 year: 1998 ident: 1923_CR3 publication-title: J Cell Sci doi: 10.1242/jcs.111.13.1897 – volume: 283 start-page: 9 year: 2019 ident: 1923_CR9 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2019.02.032 – volume: 37 start-page: 1723 year: 2016 ident: 1923_CR27 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv759 – volume: 4 start-page: 281 year: 2005 ident: 1923_CR10 publication-title: Curr Drug Targets Inflamm Allergy doi: 10.2174/1568010054022024 – volume: 24 start-page: 1838 year: 2010 ident: 1923_CR5 publication-title: FASEB J doi: 10.1096/fj.09-151639 – volume: 10 start-page: 497 issue: 6 year: 2008 ident: 1923_CR12 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-008-0078-1 – volume: 20 start-page: 2243 issue: 10 year: 2000 ident: 1923_CR21 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.10.2243 – volume: 8 start-page: 16973 year: 2018 ident: 1923_CR23 publication-title: Sci Rep doi: 10.1038/s41598-018-34659-2 – volume: 99 start-page: 494 year: 2013 ident: 1923_CR7 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvt117 – volume: 5 start-page: 59 year: 2003 ident: 1923_CR6 publication-title: Nat Cell Biol doi: 10.1038/ncb898 – volume: 16 start-page: 1573 year: 1996 ident: 1923_CR17 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.16.12.1573 – ident: 1923_CR29 doi: 10.2147/ijicmr.S64894 – volume: 441 start-page: 173 year: 2006 ident: 1923_CR15 publication-title: Nature doi: 10.1038/nature04768 – volume: 21 start-page: 844 year: 2001 ident: 1923_CR20 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.21.5.844 – ident: 1923_CR22 doi: 10.12688/f1000research.15967.1 – volume: 68 start-page: 353 year: 2005 ident: 1923_CR16 publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2005.09.009 – volume: 20 start-page: 1953 issue: 8 year: 2000 ident: 1923_CR18 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.8.1953 – volume: 14 start-page: 6 year: 2013 ident: 1923_CR25 publication-title: BMC Immunol doi: 10.1186/1471-2172-14-6 – volume: 129 start-page: 1580 year: 2016 ident: 1923_CR19 publication-title: J Cell Sci doi: 10.1242/jcs.182097 – volume: 119 start-page: 136 year: 2009 ident: 1923_CR13 publication-title: J Clin Invest – volume: 112 start-page: 651 year: 2005 ident: 1923_CR30 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.529297 – volume: 26 start-page: 673 year: 2015 ident: 1923_CR28 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2015.04.003 – volume: 444 start-page: 181 year: 2013 ident: 1923_CR4 publication-title: Virology doi: 10.1016/j.virol.2013.06.009 – volume: 239 start-page: 318 year: 2015 ident: 1923_CR8 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.02.005 – volume: 420 start-page: 868 year: 2002 ident: 1923_CR11 publication-title: Nature doi: 10.1038/nature01323 – volume: 73 start-page: 1453 year: 2009 ident: 1923_CR1 publication-title: Biochem Mosc doi: 10.1134/S0006297908130063 |
SSID | ssj0017594 |
Score | 2.4793994 |
Snippet | Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however,... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 973 |
SubjectTerms | Apolipoprotein E Arteriosclerosis Atherosclerosis Biomedical and Life Sciences Biomedicine Cardiovascular disease CD36 antigen Coronary artery Coronary vessels Cytokines Cytoskeleton Diet Focal adhesion kinase Heart diseases Human Genetics Inflammation Interleukin 6 Internal Medicine Lipoproteins Low density lipoprotein Macrophages Molecular Medicine NF-κB protein Original Article Phosphorylation Tumor necrosis factor-α Vimentin |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA46QXwR706nRPBNA72kSfs41DFk0xcHeytJmuJAW1k7p_56T7K2IlPBx9I0KeckOd_hOxeEzpVOhCtpQCjlPjgojiLS1YKYUlRhaEyq7UM2vGP9Eb0dB-MqKayoo91rStLe1E2ym2VxiHF3LCwh81W0FoDvbgK5Rl634Q54YNsfgt_CiAfuQJUq8_Mc383REsZc4ket2eltoc0KL-LuQsHbaEVnO2h9WDHiuyi9f5skkw-d4MH1AIODDaoq8Kut2T_JcGFQoZE9lu_4WZh-XY9wgxRYZAm2Yeqm3xU8lzm2WDAvYJlpDqvBZClsl0Vq4x4a9W4ervqk6p1AFHWjknBPKqVDbojYSDs8MbaYs9TUAeWu4lQDjlGu8FPOAlMkUkovUQDXvMTRUSj9fdTK8kwfIiw406kSQkRKUBqpiIYi9cH2hZFMWOq3kVuLMFZVYXHT3-IpbkoiW7HHIPbYij2et9FF883LoqzGn6M7tWbi6ogVseWyKfUc1kZnzWs4HIbxEJnOZ2aMwyJwtUP4yYOFRpvlAEkGLuNuG13WKv6a_Pd_Ofrf8GO04dntZgJ8O6hVTmf6BGBMKU_trv0E3rXn3A priority: 102 providerName: Springer Nature |
Title | Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation |
URI | https://link.springer.com/article/10.1007/s00109-020-01923-w https://www.ncbi.nlm.nih.gov/pubmed/32451671 https://www.proquest.com/docview/2421244206 https://www.proquest.com/docview/2406952383 |
Volume | 98 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dTxQxEJ8gJMYXg_h1iqQmvmnjfvTa3Sdz6AFBQGO85Hza9GvjJbqL7AHCX89Mr7eEEHja7G5323Smnd902vkBvLPe6dSIIRdC5eigJJab1GtOqaiKgkxq4CE7PJJ7E7E_HU7jglsXt1Uu58QwUbvW0hr5xxC6FCJL5Kfjf5xYoyi6Gik0HsAapS4jrVbT3uFCyxiIENGDkTxDxyAemglH50JMiJPzFEAOP79pmG6hzVuR0mCAdtbhcUSObLQQ9RNY8c0GPDyMsfGnUH_7P3OzS-_YwZcDhq42Cq1jZyF7_6xhHeFDkgIzF-yvJuau3ziXdEw3joUN68R8hffzlgVU2HZYzUmLteHPalScxSHHZzDZGf_8vMcjiwK3Ii3nXGXGWl8oCsmWPlGOrLKSNWUEValVwiOisanOayWHlC7SmMxZBG6ZS3xZmPw5rDZt418C00r62mqtS6uFKG0pCl3naAWL0jhZ5wNIl11Y2ZhinJgu_lR9cuTQ7RV2exW6vTofwPv-m-NFgo17S28uJVPFwdZV16oxgLf9axwmFPvQjW9PqUwiS3S6C2zki4VE--oQUw5TqdIBfFiK-Prnd7fl1f1teQ2PsqBetLV3E1bnJ6f-DQKYudkKWroFa6PdX1_HeN0eH33_gU8n2egKG6LuhA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJuFAkaCE1jk4bWTA0KIUm3pbrm00t6CX1FXKklptizlR_U3dsZ5VKiitx6jOLY1M_bMl7HnA3hjvdOxEWMuhEoRoESWm9hrTqWosoxcauAhm-3Kyb74Nh_P1-CsvwtDxyr7PTFs1K629I_8Q0hdCpFE8tPRL06sUZRd7Sk0WrPY8acrhGzNx-1N1O_bJNn6uvdlwjtWAW5FnC-5Soy1PlOUosx9pBx5KSVLqpCpYquERw9vY52WSo6pfKIxibMYyCQu8nlmUuz3BtxExxsR2FPzAeChJw7Ei4iYJE8QiHSXdMJVvZCD4gTWQlDFV_86wkvR7aXMbHB4W_fgbhepss-tad2HNV89gFuzLhf_EMrvfxZu8dc7Nt2cMoT2aCQN-x3YAhYVaygeJa0zc8p-amIKO8C9q2G6ciwckCemLXxe1ixEoXWDwxzXOBp2VqKhtpcqH8H-tcj3MaxXdeWfAtNK-tJqrXOrhchtLjJdpuh1s9w4WaYjiHsRFrYraU7MGofFUIw5iL1AsRdB7MVqBO-Gb47agh5Xtt7oNVN0i7spLkxxBK-H17gsKdeiK1-fUJtI5gjyM5zkk1ajw3AYw45jqeIRvO9VfNH5_-fy7Oq5vILbk73ZtJhu7-48hztJMDU6VrwB68vjE_8Cg6eleRkslsGP614i5yKeJUU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbxZKGAkOIHVPBw7OSAEbFct3S4VolJvwXYcsRIkpdmylJ_Gr2PGeVSoorceozi2NQ_PTMYzH8Bz6wodGpFwIVSMAUpguQmd5tSKKk3JpHocsv253DkUH46SozX409fC0LXK_kz0B3VRW_pHvuVTl0JEgdwqu2sRB5Ppm-MfnBCkKNPaw2m0IrLnzlYYvjWvdyfI6xdRNN3-_H6HdwgD3IowW3IVGWtdqihdmblAFWSxlCypW6YKrRIOrb0NdVwqmVArRWOiwqJTExWBy1IT47zXYF1RVDSC9Xfb84NPQw5DJR6GEeMnySMMS7qSHV-45zNSnEI372Lx1b9m8YKveyFP683f9Cbc6PxW9rYVtFuw5qrbsLHfZebvQPnx16JY_HYFm01mDAN9FJmG_fTYAYuKNeSdkgwwc8a-a8IN-4onWcN0VTB_XZ5wt_B5WTPvk9YNLnNS42o4WYli25ZY3oXDK6HwPRhVdeUeANNKutJqrTOrhchsJlJdxmiD08wUsozHEPYkzG3X4JxwNr7lQ2tmT_YcyZ57suerMbwcvjlu23tcOnqz50zeqXqTnwvmGJ4Nr1FJKfOiK1ef0phAZhjyp7jJ-y1Hh-XQo01CqcIxvOpZfD75__fy8PK9PIUNVI98tjvfewTXIy9pdMd4E0bLk1P3GD2ppXnSiSyDL1etJX8BFu0q4A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxidized+LDL+induces+vimentin+secretion+by+macrophages+and+contributes+to+atherosclerotic+inflammation&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Kim%2C+SeoYeon&rft.au=Cho%2C+Wonkyoung&rft.au=Kim%2C+Inyeong&rft.au=Lee%2C+Sang-Hak&rft.date=2020-07-01&rft.eissn=1432-1440&rft_id=info:doi/10.1007%2Fs00109-020-01923-w&rft_id=info%3Apmid%2F32451671&rft.externalDocID=32451671 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon |